Juergen Roemisch
14Patents
5h-index
30Co-inventors
62Inventor score
Filing activity: Aug 4, 2000 → Jul 8, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8518452B2 | Method for stabilizing blood plasma components in a lyophilizate using carbon dioxide and phosphoric acid | Human Necessities | 46 | Active |
| US6737405B2 | Stabilized protein preparation and process for its preparation | Human Necessities | 38 | Expired |
| US6677440B1 | Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography | Human Necessities | 13 | Expired |
| US6670455B1 | Process for the preparation in pure form of the protease activating blood clotting VII, its proenzyme or a mixture of both proteins by means of affinity chromatography | Performing Operations; Transporting | 6 | Expired |
| US7153679B2 | Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis | Physics | 5 | Expired |
| US6831167B2 | Mutants of the factor VII-activating protease and detection methods using specific antibodies | Physics | 4 | Expired |
| US7829095B2 | Inhibitory monoclonal antibody against blood clotting factor VII-activating protease | Physics | 0 | Expired |
| US7892842B2 | Procedure for the determination of the activity of the protease which activates factor VII from protein solutions | Emerging Cross-Sectional Technologies | 0 | Active |
| US7442514B2 | Mutants of the factor VII-activating protease and detection methods using specific antibodies | Physics | 0 | Expired |
| US12274738B2 | FX activation process and its use in the preparation of a FXa composition | Chemistry; Metallurgy | 0 | Active |
| US6395881B1 | Separation of antithrombin III &agr; and &bgr; variants by cyclodextrin-modified micellar electrokinetic chromatography | Physics | 0 | Expired |
| US8809510B2 | Method for purification of complement factor H | Human Necessities | 0 | Active |
| US7863009B2 | Mutants of the factor VII-activating protease and detection methods using specific antibodies | Physics | 0 | Active |
| US7803569B2 | Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.